Trigeminal herpes zoster is a reactivation of the varicella-zoster virus (VZV) within the trigeminal nerve, the large nerve responsible for sensation across most of the face, scalp, and mouth. Because the trigeminal nerve divides into three branches that serve the forehead and eye, the mid-face and upper jaw, and the lower jaw, the rash, pain, and potential complications of this form of shingles vary dramatically depending on which branch is involved. The eye-related form alone accounts for a sizable share of all shingles cases and can threaten vision, while lower-branch involvement can lead to tooth loss and jawbone destruction that most people never associate with a viral infection.
How the Virus Reaches the Trigeminal Nerve
After a childhood bout of chickenpox, VZV does not leave the body. It retreats into clusters of nerve cells called ganglia and stays dormant, sometimes for decades. The virus settles in ganglia along the entire length of the spine and in the cranial nerves, including the trigeminal ganglion, which sits near the base of the skull.1PubMed Central. The neurobiology of varicella zoster virus infection Within those ganglia, VZV DNA has been found predominantly in the neurons themselves, with only occasional non-neuronal cells harboring the virus.2PubMed. Latent varicella-zoster virus is located predominantly in neurons in human trigeminal ganglia
What keeps the virus asleep? Part of the answer involves nerve growth factor (NGF) signaling. Laboratory work on human trigeminal ganglia removed after death found that when researchers blocked NGF pathways, VZV DNA replication increased significantly compared with untreated samples.3PubMed Central. Induction of varicella zoster virus DNA replication in dissociated human trigeminal ganglia In a living person, the immune system also keeps VZV in check. When immunity wanes because of aging, stress, illness, or immunosuppressive medications, the virus can wake up and travel down one or more branches of the trigeminal nerve, producing the pain and blistering rash of shingles in the territory that branch supplies.
The Three Branches and What Each One Puts at Risk
The trigeminal nerve splits into three divisions. The ophthalmic branch (V1) covers the forehead, upper eyelid, and eye. The maxillary branch (V2) covers the cheek, upper lip, upper teeth, and parts of the nasal cavity. The mandibular branch (V3) covers the lower jaw, lower teeth, and part of the tongue. Shingles can strike any one of these branches, or occasionally more than one at the same time. A case report described a patient with simultaneous involvement of both V1 and V2, with swollen, red skin across the forehead and cheek along with painful lesions inside the mouth corresponding to nerves of the maxillary branch.4PubMed Central. Herpes zoster of the trigeminal nerve with multi-dermatomal involvement: a case report of an unusual presentation
The ophthalmic branch is the most frequently affected, and it carries the highest stakes because of its proximity to the eye. Maxillary and mandibular involvement is less common but brings its own set of complications that often catch patients and even clinicians off guard.
When the Eye Is Involved
Herpes zoster ophthalmicus (HZO) refers specifically to reactivation along the ophthalmic branch. Roughly 4 to 20 percent of all shingles patients develop HZO, and about half of those go on to have some form of eye disease, including inflammation of the conjunctiva, cornea, or the interior structures of the eye. Up to a quarter of patients with ocular involvement develop chronic or recurrent problems.5PubMed Central. Herpes Zoster Ophthalmicus: Presentation, Complications, Treatment, and Prevention The range of possible eye complications runs from mild redness all the way to sight-threatening inflammation of the retina or optic nerve.
One clinical sign that ophthalmologists look for is Hutchinson’s sign: blisters appearing on the tip or side of the nose. This occurs when the nasociliary nerve, a sub-branch of V1 that also supplies the eye, is involved. A study of patients with herpes zoster ophthalmicus found that Hutchinson’s sign roughly tripled the risk of ocular inflammation and quadrupled the risk of corneal nerve damage. When blisters appeared on both sides of the nose, ocular inflammation was virtually guaranteed.6PubMed. Prognostic value of Hutchinson’s sign in acute herpes zoster ophthalmicus If you develop a shingles rash on your forehead and notice any lesions on or near your nose, that warrants an urgent eye examination.
The most feared ocular complication is acute retinal necrosis, a rapidly progressive infection of the retina. VZV has been confirmed as a cause of this condition, with virus cultured directly from the fluid inside the eye in affected patients.7PubMed. Varicella Zoster Virus is a Cause of the Acute Retinal Necrosis Syndrome The visual outlook for acute retinal necrosis is poor; in many cases, final visual acuity drops severely, and early diagnosis and prompt antiviral treatment are the strongest predictors of salvaging vision.8Folia Medica. Acute retinal necrosis: pathophysiological aspects, diagnosis, and treatment
Jawbone and Tooth Complications
When VZV reactivates along the maxillary or mandibular branches, the initial presentation often looks like a terrible toothache, sometimes leading patients straight to a dentist rather than a doctor. The rash may appear on the gums, palate, or inner cheek, and oral lesions can be mistaken for other conditions. Mandibular involvement in particular is rare and its pre-eruptive pain can be misdiagnosed as a dental or temporomandibular joint problem before the rash appears.9PubMed Central. Trigeminal herpes zoster: early recognition and treatment are crucial
Perhaps the most surprising complication is destruction of the jawbone. In documented cases, VZV infection along the lower jaw led to severe bone loss around the teeth, purulent drainage, and ultimately the need to extract teeth because the supporting bone was simply gone. One case report described a patient whose teeth developed extreme looseness within two weeks of the rash, with radiographs showing advanced alveolar bone loss and necrosis so extensive that the bone between adjacent teeth had vanished entirely.10PubMed. Alveolar bone necrosis and tooth exfoliation following herpes zoster infection: a review of the literature and case report A review of reported cases found that by 2009, only about 41 patients with this complication had been described in the medical literature, with ages ranging from 6 to 85 years. Immunocompromised patients seem especially vulnerable, in part because VZV-induced ulceration of the oral mucosa can create an entry point for bacteria, leading to secondary bone infection.11PubMed Central. Herpes Zoster Induced Alveolar Bone Necrosis in Immunocompromised Patients; Two Case Reports
When There Is No Rash at All
One of the trickiest diagnostic scenarios is “zoster sine herpete,” where the virus reactivates and causes pain along a nerve distribution but never produces a visible rash. This can happen with any dermatome, but it is especially problematic in the trigeminal nerve territory because the resulting facial pain can mimic so many other conditions. A case report of zoster sine herpete involving the maxillary and mandibular divisions described severe facial pain without any blisters, diagnosed only by detecting elevated VZV antibodies in the patient’s blood.12PubMed. A case of zoster sine herpete of the trigeminal nerve
Because there is no rash to point to, confirming the diagnosis typically requires laboratory testing. The two most widely used approaches are detecting VZV DNA through PCR testing and measuring VZV-specific antibodies through blood or cerebrospinal fluid analysis.13Korean Journal of Pain. Zoster sine herpete: a review VZV reactivation without rash can also produce neurological complications, from chronic nerve pain to inflammation of blood vessels in the brain, making it important for clinicians to consider this possibility in patients with unexplained facial pain following a nerve distribution pattern.14PubMed Central. Neurological disease produced by varicella zoster virus reactivation without rash
Neurological Complications Beyond the Face
The damage VZV can cause is not limited to the skin, eyes, and mouth. When the virus reactivates in the trigeminal ganglion, it can spread to nearby blood vessels and other cranial nerves, producing complications that seem far removed from a skin rash.
Stroke is one such complication. VZV can infect the walls of cerebral arteries, causing pathological remodeling of the blood vessels and increasing the risk of stroke. A large population-based study found that the risk of stroke in the year after a general herpes zoster episode was about 30 percent higher than in people who had not had shingles. For patients with herpes zoster ophthalmicus specifically, the one-year stroke risk was more than four times higher.15PubMed. Increased risk of stroke after a herpes zoster attack: a population-based follow-up study The mechanism is thought to involve direct VZV infection of arterial walls, which triggers inflammation and vascular remodeling that can lead to blockage or rupture.16PubMed Central. The relationship between herpes zoster and stroke
Ramsay Hunt syndrome is another recognized complication. Although it classically involves VZV reactivation in the nerve that serves the ear and face (the geniculate ganglion of the facial nerve), the inflammation can extend to involve the trigeminal nerve as well as hearing and balance nerves, producing a combination of facial paralysis, ear pain, vertigo, and trigeminal sensory loss.17PubMed. Ramsay Hunt syndrome with unilateral polyneuropathy involving cranial nerves V, VII, VIII, and XII in a diabetic patient
Postherpetic Neuralgia in the Trigeminal Territory
Postherpetic neuralgia (PHN), the chronic pain that persists after shingles blisters heal, is the complication patients dread most. When it develops in the trigeminal territory, it tends to be especially debilitating. The face is uniquely sensitive, and the constant burning, shooting, or electric-shock-like pain can interfere with eating, sleeping, and basic social interaction. Trigeminal PHN has been described as one of the most common and complex locations for postherpetic neuralgia, with its own distinct clinical and biological features rooted in viral damage to the trigeminal ganglion and the brain pathways that modulate pain signals from the face.18PubMed Central. Trigeminal Postherpetic Neuralgia: From Pathophysiology to Treatment
The psychological burden deserves mention as well. A study of patients receiving electrical stimulation of the trigeminal ganglion for postherpetic neuralgia tracked not just pain scores but also sleep quality, anxiety, and depression over six months. Before treatment, patients scored poorly on all of these measures. After the procedure, pain, sleep disturbance, anxiety, and depression scores all improved significantly.19PubMed Central. Trigeminal Ganglion Electrical Stimulation for Trigeminal Nerve Postherpetic Neuralgia: A Retrospective Study That interconnection between chronic facial pain and mental health makes aggressive pain management particularly important.
Antiviral Treatment and the Race Against Time
The standard first-line treatment for trigeminal herpes zoster is oral antiviral medication, started as soon as possible after symptoms appear. Valacyclovir and acyclovir are the workhorses. A head-to-head trial in patients with herpes zoster ophthalmicus found the two drugs equally effective at preventing ocular complications such as conjunctivitis and keratitis, with similar side-effect profiles. The advantage of valacyclovir is a simpler dosing schedule, three times daily rather than five.20PubMed. Comparison of the efficacy and safety of valaciclovir and acyclovir for the treatment of herpes zoster ophthalmicus Even in the rare case of optic nerve involvement, oral valacyclovir has been used successfully in patients with intact immune systems, potentially sparing some patients from intravenous treatment and hospitalization.21PubMed Central. Oral Valacyclovir Treatment of Herpes Zoster Ophthalmicus-Induced Optic Neuritis
Topical steroid eye drops are frequently used when there is ocular inflammation, but they require careful management. A large study found that among patients who received topical steroids within the first month of herpes zoster ophthalmicus, over 40 percent experienced a recurrence of eye disease. After steroid treatment was stopped, the median time to recurrence was about a month and a half, with 90 percent of recurrences occurring within seven months.22PubMed. Herpes Zoster Ophthalmicus Recurrence: Risk Factors and Long-Term Clinical Outcomes This means patients and their eye doctors need to stay vigilant during and after a steroid taper rather than assuming the problem is resolved once the drops stop.
Managing Pain That Persists
When acute pain or postherpetic neuralgia resists standard analgesics, the go-to medications are gabapentin and tricyclic antidepressants such as nortriptyline. In a small series of patients with herpetic and postherpetic facial pain, gabapentin titrated up to 1,800 mg per day produced complete pain relief, with patients reporting dose-dependent improvement in burning pain, shooting pain, and the extreme skin sensitivity called allodynia.23Regional Anesthesia and Pain Medicine. Acute herpetic neuralgia and postherpetic neuralgia in the head and neck: Response to gabapentin in five cases Nerve blocks and tricyclic antidepressants may also help reduce the risk of developing long-term PHN, although firm evidence for that preventive effect is still limited.24PubMed. Management of herpes zoster (shingles) and postherpetic neuralgia
For patients who do not respond to medications, interventional procedures are an option. Pulsed radiofrequency applied to the trigeminal ganglion has shown promise. A systematic review and meta-analysis of studies on this technique for zoster-related trigeminal pain found that it was effective and safe, with meaningful improvements in pain relief and sleep quality. It also appeared to reduce the likelihood of progressing to postherpetic neuralgia.25PubMed Central. Efficacy and Safety of Pulsed Radiofrequency in Herpes Zoster Related Trigeminal Neuralgia: A Systematic Review and Meta-Analysis A randomized controlled trial comparing high-voltage, long-duration pulsed radiofrequency to a standard version found that the more aggressive protocol achieved better pain reduction and lower need for supplemental medication, without serious adverse events.26Neuromodulation. High-Voltage, Long-Duration Pulsed Radiofrequency on Gasserian Ganglion for Acute/Subacute Trigeminal Herpes Zoster: A Randomized, Double-Blind Controlled Trial
Can Vaccination Prevent It
The recombinant zoster vaccine (sold as Shingrix) is recommended for adults 50 and older and for immunocompromised adults at younger ages. Its effectiveness against herpes zoster ophthalmicus specifically has been studied in a large US cohort, which found the vaccine reduced the incidence of HZO by about 89 percent compared with unvaccinated individuals.27PubMed Central. Effectiveness of the Recombinant Zoster Vaccine for Herpes Zoster Ophthalmicus in the United States A systematic review and meta-analysis confirmed that the vaccine substantially reduces the risk of both herpes zoster ophthalmicus and postherpetic neuralgia.28PubMed Central. Efficacy and Effectiveness of the Recombinant Zoster Vaccine Against Herpes Zoster, Herpes Zoster Ophthalmicus, Postherpetic Neuralgia and Dementia: A Systematic Review and Meta-Analysis
One question that comes up is whether people who already had an episode of herpes zoster ophthalmicus should get vaccinated. A study looking at this scenario found a slightly elevated short-term risk of an eye disease flare after vaccination, with the adjusted risk about 64 percent higher in the initial period following the shot compared with a control window.29JAMA Ophthalmology. Risk of Herpes Zoster Ophthalmicus Recurrence After Recombinant Zoster Vaccination That finding does not mean vaccination should be avoided after an HZO episode, since the long-term benefit of preventing a full reactivation likely outweighs the short-term risk of a flare. But it is worth discussing with your eye doctor, especially if you had severe or recurrent ocular involvement, so you can plan close monitoring around the vaccination window.
Children and Herpes Zoster Ophthalmicus
Shingles is overwhelmingly a disease of older adults, but it can and does occur in children, including in the trigeminal territory. A systematic review of pediatric herpes zoster ophthalmicus found that the majority of childhood cases occurred in children with normal immune systems, not just in those who were immunocompromised. Among the reported pediatric cases, only about 10 percent were in children known to be immunocompromised. In one observational study, 29 of 244 children hospitalized with shingles had the ophthalmic form, and only 3 of those 29 were immunocompromised.30PubMed Central. Pediatric herpes zoster ophthalmicus: a systematic review The takeaway for parents: a child who had chickenpox or received the varicella vaccine can develop shingles, including in the eye area, even without any underlying immune problem. Blisters on a child’s forehead or near the eye deserve prompt medical attention.